Considerable progress has been made in the treatment of ST-elevation myocardial infarction (STEMI) in the last few decades with the introduction and improvement of reperfusion therapy, in particular of primary percutaneous coronary intervention (PPCI). Although no guideline gender-specific differences exist in the treatment of STEMI patients, there is debate about possible differences in mortality after PPCI in men and women.
As reported in several recent STEMI reviews and meta-analyses, women have a worse baseline clinical profile: they are older and have a higher prevalence of diabetes mellitus (DM), hypertension and dyslipidaemia1,2. Certain risk factors seem to have a ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com